141 related articles for article (PubMed ID: 10649620)
1. Oral tolerance elicited in mice by beta-lactoglobulin entrapped in biodegradable microspheres.
Pecquet S; Leo E; Fritsché R; Pfeifer A; Couvreur P; Fattal E
Vaccine; 2000 Jan; 18(13):1196-202. PubMed ID: 10649620
[TBL] [Abstract][Full Text] [Related]
2. Biodegradable microparticles for the mucosal delivery of antibacterial and dietary antigens.
Fattal E; Pecquet S; Couvreur P; Andremont A
Int J Pharm; 2002 Aug; 242(1-2):15-24. PubMed ID: 12176221
[TBL] [Abstract][Full Text] [Related]
3. Optimization of the encapsulation and release of beta-lactoglobulin entrapped poly(DL-lactide-co-glycolide) microspheres.
Rojas J; Pinto-Alphandary H; Leo E; Pecquet S; Couvreur P; Fattal E
Int J Pharm; 1999 Jun; 183(1):67-71. PubMed ID: 10361157
[TBL] [Abstract][Full Text] [Related]
4. Mucosal immunogenicity elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly (D,L-lactide-co-glycolide) microspheres.
Allaoui-Attarki K; Fattal E; Pecquet S; Trollé S; Chachaty E; Couvreur P; Andremont A
Vaccine; 1998 Apr; 16(7):685-91. PubMed ID: 9562687
[TBL] [Abstract][Full Text] [Related]
5. Characterization of humoral and cellular immune responses in mice induced by immunization with HIV-1 Nef regulatory protein encapsulated in poly(DL-lactide-co-glycolide) microparticles.
Moureau C; Vidal PL; Bennasser Y; Moynier M; Nicaise Y; Aussillous M; Barthelemy S; Montagnier L; Bahraoui E
Mol Immunol; 2002 Jan; 38(8):607-18. PubMed ID: 11792429
[TBL] [Abstract][Full Text] [Related]
6. Chronic local tissue reactions, long-term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers.
Gupta RK; Alroy J; Alonso MJ; Langer R; Siber GR
Vaccine; 1997 Nov; 15(16):1716-23. PubMed ID: 9364673
[TBL] [Abstract][Full Text] [Related]
7. [Oral tolerance induced by poly (lactide-co-glycolide) containing B lactoglobulin].
Fattal E; Couvreur P; Pecquet S
Ann Pharm Fr; 2002 Jan; 60(1):44-9. PubMed ID: 11976549
[TBL] [Abstract][Full Text] [Related]
8. PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems.
Delgado A; Lavelle EC; Hartshorne M; Davis SS
Vaccine; 1999 Jul; 17(22):2927-38. PubMed ID: 10438065
[TBL] [Abstract][Full Text] [Related]
9. Enhancing immunogenicity and reducing dose of microparticulated synthetic vaccines: single intradermal administration.
Carcaboso AM; Hernández RM; Igartua M; Rosas JE; Patarroyo ME; Pedraz JL
Pharm Res; 2004 Jan; 21(1):121-6. PubMed ID: 14984266
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin E suppression and cytokine modulation in mice orally tolerized to beta-lactoglobulin.
Pecquet S; Pfeifer A; Gauldie S; Fritsché R
Immunology; 1999 Feb; 96(2):278-85. PubMed ID: 10233706
[TBL] [Abstract][Full Text] [Related]
11. CTL responses induced by a single immunization with peptide encapsulated in biodegradable microparticles.
Partidos CD; Vohra P; Jones D; Farrar G; Steward MW
J Immunol Methods; 1997 Aug; 206(1-2):143-51. PubMed ID: 9328577
[TBL] [Abstract][Full Text] [Related]
12. Enhanced immune response after subcutaneous and oral immunization with biodegradable PLGA microspheres.
Igartua M; Hernández RM; Esquisabel A; Gascón AR; Calvo MB; Pedraz JL
J Control Release; 1998 Dec; 56(1-3):63-73. PubMed ID: 9801430
[TBL] [Abstract][Full Text] [Related]
13. Biocompatibility of poly (DL-lactide-co-glycolide) microspheres implanted into the brain.
Emerich DF; Tracy MA; Ward KL; Figueiredo M; Qian R; Henschel C; Bartus RT
Cell Transplant; 1999; 8(1):47-58. PubMed ID: 10338275
[TBL] [Abstract][Full Text] [Related]
14. The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol.
Lavelle EC; Yeh MK; Coombes AG; Davis SS
Vaccine; 1999 Feb; 17(6):512-29. PubMed ID: 10075157
[TBL] [Abstract][Full Text] [Related]
15. Preliminary assessment of the immune response to Olea europaea pollen extracts encapsulated into PLGA microspheres.
Igartua M; Hernández RM; Gutierro I; Gascón AR; Pedraz JL
Pharm Dev Technol; 2001 Nov; 6(4):621-7. PubMed ID: 11775962
[TBL] [Abstract][Full Text] [Related]
16. Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies.
Eldridge JH; Staas JK; Meulbroek JA; Tice TR; Gilley RM
Infect Immun; 1991 Sep; 59(9):2978-86. PubMed ID: 1879922
[TBL] [Abstract][Full Text] [Related]
17. Microencapsulation of a synthetic peptide epitope for HTLV-1 in biodegradable poly(D,L-lactide-co-glycolide) microspheres using a novel encapsulation technique.
Frangione-Beebe M; Rose RT; Kaumaya PT; Schwendeman SP
J Microencapsul; 2001; 18(5):663-77. PubMed ID: 11508771
[TBL] [Abstract][Full Text] [Related]
18. Protective immunity against Salmonella typhimurium elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly(DL-lactide-co-glycolide) microspheres.
Allaoui-Attarki K; Pecquet S; Fattal E; Trollé S; Chachaty E; Couvreur P; Andremont A
Infect Immun; 1997 Mar; 65(3):853-7. PubMed ID: 9038287
[TBL] [Abstract][Full Text] [Related]
19. The fate of biodegradable microspheres injected into rat brain.
Nicholas AP; McInnis C; Gupta KB; Snow WW; Love DF; Mason DW; Ferrell TM; Staas JK; Tice TR
Neurosci Lett; 2002 Apr; 323(2):85-8. PubMed ID: 11950499
[TBL] [Abstract][Full Text] [Related]
20. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
